ArticleHealthcare (Basel, Switzerland)2022

A Hybrid Risk Factor Evaluation Scheme for Metabolic Syndrome and Stage 3 Chronic Kidney Disease Based on Multiple Machine Learning Techniques.

Mao-Jhen Jhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.